AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02626741 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: meal replacement group
Description: The participants will receive SlimWell 60 grams per meal for 2 meals per day plus life style modification including educational sessions of exercise, dietary intake, food record. The duration is 3 months.
Study NCT02626741 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: control group
Description: The participants will receive only life style modification including educational sessions of exercise, dietary intake, food record. The duration is 3 months.
Study NCT04649762 — intervention group
Intervention type: BEHAVIORAL
Intervention: activating consciousness technique (hypnosis)
Description: activating consciousness technique (hypnosis)
Study NCT01379924 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parenting/Life Skills Intervention
Description: Modules adapted from the Ansell-Casey Life Skills Assessment Curriculum, the Women's Negotiation Project Curriculum for Teen Mothers and the Nurturing Curriculum. Goal is to help teen mothers develop positive parenting skills, decrease repeat pregnancy and acquire skills of daily living. The series of five, one-hour long, structured, one-on-one interactive modules aims to help teens build positive, empathetic relationships with their children, while enhancing self-efficacy and increasing the sense of self- worth for parents and children. Domains addressed include child development/discipline, safety, house/money management, social relationships, career planning, substance abuse and community and interpersonal violence.
Study NCT01379924 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Teen-tot medical home
Description: Medical, mental health, and social services provided to teen parents and their children
Study NCT02128984 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Symbiotic Formula with DHA and antioxidants
Description: 6 months intervention.
Study NCT02128984 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Standard Formula
Description: 6 months intervention.
Study NCT01066884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: erlotinib [Tarceva]
Description: 150mg po daily
Study NCT00801359 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Phacoemulsification
Study NCT00801359 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Phacoemulsification
Study NCT01440907 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Care Coordination Program
Description: The Care Coordination Program includes: (1) access to a secure online personal health record (PHR) that people can logon and manage their health information, as well as receive alerts and reminders about action items for them to take on their healthcare; and (2) depending on the patient's health care needs, nursing support (either in-person or by phone).
Study NCT03962556 — intervention group
Intervention type: OTHER
Intervention: bimanual palpation
Description: bimanual palpation....i..
Study NCT00699842 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Dose Level Lenalidomide Schedule~1. 15mg/day for d1-21 out of 28 days~2. 20mg/day for d1-21 out of 28 days~3. 25mg/day for d1-21 out of 28 days
Study NCT02016898 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Placement of the sponge
Study NCT02016898 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitomycin-C
Study NCT00098020 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Isotretinoin
Study NCT01926847 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Riociguat (Adempas, BAY63-2521)
Study NCT00801359 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BSSPlus solution
Study NCT00801359 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lactated Ringer's solution
Study NCT04031781 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: repetitive transcranial magnetic stimulation (rTMS) 100% motor threshold
Description: Each rTMS session consisted of a single train of 900 total pulses over 3 minutes duration.
Study NCT04031781 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: repetitive transcranial magnetic stimulation (rTMS) 50% motor threshold
Description: Each rTMS session consisted of a single train of 900 total pulses over 3 minutes duration.
Study NCT01926847 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Study NCT01833741 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bimatoprost 0.01%
Description: Bimatoprost 0.01% (LUMIGAN® RC) administered as one drop in the study eye(s) each evening for 12 weeks.
Study NCT01738737 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active Laser
Description: 18 points of application of active laser in the knee (frontal faces, lateral and medial)
Study NCT01738737 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stretching exercises
Description: 7 stretching exercises for lower limbs lasting 30 seconds with 4 repetitions
Study NCT01738737 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: placebo laser therapy
Description: 18 points of application of placebo laser in the knee (frontal faces, lateral and medial)
Study NCT00944268 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Passiflora, Crataegus e Salix
Description: Comparison of different pharmaceutics forms of drug
Study NCT01642303 — intervention group
Intervention type: OTHER
Group type: NO_INTERVENTION
Intervention: no intervension
Description: Listen to student book listening files
Study NCT03519672 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: This is a non-interventional study.
Study NCT04019769 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: L-glutamine
Description: product will be obtained by Endari and administered by NIH pharmacy. Patient will take supplement as prescribed
Study NCT01626053 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ASMART
Description: Motivational Interviewing, Stages of Change, Psychological Testing, Bio-psychosocial assessment, responsive diabetes education, support, Cognitive-behavioral interventions
Study NCT01626053 — intervention group
Intervention type: OTHER
Group type: NO_INTERVENTION
Intervention: Control Group
Description: no intervention
Study NCT01819506 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Task Practice Physical Rehabilitation Therapy
Description: Similar to stroke rehabilitation occupational therapy.
Study NCT01819506 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Task Practice Physical Rehabilitation Therapy
Description: Similar to stroke rehabilitation occupational therapy.
Study NCT02827279 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: emotional induction
Description: The eye-tracking mesure the reaction at emotional induction using of sound stimuli in a group of children with or without ASD, in a context of
Study NCT01729650 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical and diet educational group
Description: educational group of: physical activity program (basically walking) of 24 sessions over 12 weeks, and diet (16 sessions in the first 8 weeks, carried out by mental health nurses.
Study NCT03155633 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Athletics track
Description: Running at 95-105% aerobic Threshold on athletics track 48h, 96h, 144h after the race. Control heart devices
Study NCT03155633 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Elliptical machine
Description: Running at 95-105% aerobic Threshold on elliptical machine 48h, 96h, 144h after the race. Control heart devices
Study NCT04164329 — intervention group
Intervention type: DRUG
Intervention: General anesthetic
Description: General anesthesia (propofol, fentanyl, sevorane, remifentanyl, rocuronium)
Study NCT02173392 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brodalumab
Description: Brodalumab is a large molecule for the treatment of inflammatory diseases
Study NCT02277522 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RNA anti-CD19 CAR T cells
Description: intravenously administered, RNA electroporated autologous T cells expressing CD19 chimeric antigen receptors expressing tandem TCRζ and 4-1BB (TCR /4-1BB) costimulatory domains (referred to as RNA CART19)
Study NCT04975542 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Osteopathic Manipulative Medicine
Description: Manipulative therapies based on Osteopathic principles.
Study NCT04975542 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: Light touch techniques to mimic to osteopathic treatment.
Study NCT01471964 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MLN8237 and Erlotinib
Description: Erlotinib pills once every day and MLN8237 pills twice every day, day 1-7 of every 21 days
Study NCT03427138 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Jasper
Description: Families in the joint attention intervention will receive 10 weeks of the JASPER (Joint Attention Symbolic Play Engagement Regulation) protocol. JASPER is a treatment approach based on a combination of developmental and behavioral principles developed by Dr. Connie Kasari at the Center for Autism Research and Treatment, at University of California, Los Angeles. Our research staff will be trained on the specific techniques of JASPER guided by Connie Kasari (consultant on project) and her colleagues The study's intervention involves 2 days/week of 60-minute sessions with a trained experimenter (which may take place in the lab or home, depending on the needs of the family). The primary goal for the intervention will be to increase the frequency and range/variety of joint attention and to advance the child to higher levels (e.g., from requesting to initiating joint attention acts).
Study NCT01043718 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: More-Intensive
Description: The online lifestyle intervention will include elements of a behavioral lifestyle program developed by the Diabetes Prevention Program. The program will assist individual participants with establishing appropriate weight loss goals, implementing dietary recommendations (including analysis of current diet), and defining exercise programs. The program curriculum provides standard information about healthy lifestyle, and behavioral techniques for integrating them into daily living. In each lesson, patients provide feedback about how they interpret the information, and ideas for integrating it into their lives.
Study NCT01043718 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Less-Intensive
Description: The participants will be provided with the information to access the online Diabetes Prevention Program (DPP) intervention materials. Following the original DPP trial, all DPP materials were placed online for the public to access. This group will receive a lifestyle counseling session and tools to facilitate their intervention.
Study NCT03294005 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Thyroid ultrasonography
Description: Each subject had been transverse and longitudinal views of thyroid ultrasonography with high-resolution ultrasound (7-14 MHz) (HP Image Point-HS, Toshiba SSA250, GE ,Aloka SSD-1200 and Siemens S2000) that was performed by our partners - endocrinologist in all patients.
Study NCT03427138 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parent Education
Description: Families in the parent education intervention. Parent education will be provided in group sessions. During the sessions information is presented about ASD, how to deal with behavioral difficulties and available services, and parents are given an opportunity to share experiences. Parents will attend a weekly session for 10 weeks. 10 different topics will be discussed, which include: causes and symptoms of autism, diagnosis process, treatment options, enhancing communicative abilities in children with autism, emotion regulation, dealing with distress, correcting behavior difficulties, applying structure and routines.
Study NCT04424199 — intervention group
Intervention type: BEHAVIORAL
Intervention: Rightward Attentional Shift (R-PA)
Description: Patients will perform a session of 90 pointing movements toward a visual target presented on the right, the left or at the center of the visual field. This pointing task will be performed with prismatic googles inducing a rightward attentional shift.
Study NCT04424199 — intervention group
Intervention type: BEHAVIORAL
Intervention: Leftward Attentional Shift (L-PA)
Description: Patients will perform a session of 90 pointing movements toward a visual target presented on the right, the left or at the center of the visual field. This pointing task will be performed with prismatic googles inducing a leftward attentional shift.
Study NCT01800279 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapy Protocol
Description: Kinesitherapy~* Patient: supine position on the stretcher with a loop of 6 cm in the cervical area.~* Tongue in the palate for all applied exercises.~* Repetitions of each exercise: 8. Cervical traction. Cranium fore flexion 15 °. Open-close mouth dental contactless (10mm). Opening movement with a small resistor (one finger on chin).~Flexion of the head, without actually lifting, resisting in the front. Occipital extension. Cranium fore flexion 15 °. Cervical traction.~Myofascial Therapy. Induction suboccipital. Compression - decompression of the TMJ (Temporomandibular Joint). Horizontal Induction TMJ. Deep fascia induction in the temporal region. Deep Induction of the masseter fascia. Deep Induction of the external pterygoid. Induction of intraoral pterygoid.
Study NCT01101204 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin 1000mg, simvastatin 10mg and fenofibrate 100mg
Description: Patient will take three pill consisting of metformin 1000mg, simvastatin 10mg and fenofibrate 100mg.
Study NCT01101204 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Metformin 1000mg, simvastatin 10mg and fenofibrate 100mg
Description: Patient will take three pill consisting of metformin 1000mg, simvastatin 10mg and fenofibrate 100mg.
Study NCT03118388 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social Enterprise Intervention
Description: The SEI model was implemented in four stages: 1) Vocational skill acquisition (4 months); 2) Small business skill acquisition (4 months); 3) SEI formation and product distribution (12 months); and 4) Clinical/case-management services, (ongoing for 20 months).
Study NCT03118388 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: IPS
Description: To implement the IPS at the host agency, one employment specialist, two case managers, and two clinicians were assigned the 22 available IPS cases among them at baseline. Over the 20 months, all IPS participants met individually with the employment specialist, one case manager, and one clinician at least weekly. Regarding job development in the community, the IPS employment specialist also spent about 40% of each week out in the community building relationships with new and existing employers.
Study NCT01176617 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Reveal XT implantable loop recorder
Description: All study participants will receive the Reveal XT implantable loop recorder immediately after completion of the ablation procedure.
Study NCT02668926 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine, d-amphetamine, Placebo
Description: Elvanse (Lisdexamfetamine): 100mg p.o, single dose; d-Amphetamine: 40.3mg p.o, single dose; Placebo: Capsules containing mannitol looking identical to lisdexamphetamine and d-Amphetamine.
Study NCT02668926 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: d-amphetamine, Placebo, Lisdexamfetamine
Description: Elvanse (Lisdexamfetamine): 100mg p.o, single dose; d-Amphetamine: 40.3mg p.o, single dose; Placebo: Capsules containing mannitol looking identical to lisdexamphetamine and d-Amphetamine.
Study NCT02668926 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo, Lisdexamfetamine, d-amphetamine
Description: Elvanse (Lisdexamfetamine): 100mg p.o, single dose; d-Amphetamine: 40.3mg p.o, single dose; Placebo: Capsules containing mannitol looking identical to lisdexamphetamine and d-Amphetamine.
Study NCT00771745 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Thymoglobulin
Description: Preloading Induction with Thymoglobulin® X 4 doses given day -4, day -2, day 0, and day 2 at 1.5 mg/kg/dose + corticosteroid taper + tacrolimus + MMF
Study NCT00771745 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Thymoglobulin
Description: Preloading Induction with Thymoglobulin® X 3 doses given day -4 (1.5mg/kg), day -2 (1.5mg/kg), and day 0 (3mg/kg) + corticosteroid taper + tacrolimus + MMF
Study NCT00836771 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Infant Formula
Study NCT00836771 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Infant Formula
Study NCT00836771 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Infant Formula
Study NCT01642446 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Precise hepatectomy
Description: Precise hepatectomy
Study NCT01642446 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Combined intervention (chemoembolization/ablation)
Description: transcatheter hepatic arterial chemoembolization and/or ablation
Study NCT03376464 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Xeomin Cosmetic
Description: Xeomin Cosmetic is the purest commercially available botulinum toxin type A available to date. It has been approved by Health Canada since 2012 for the temporary improvement in the appearance of moderate to severe glabellar lines.
Study NCT00746525 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Surface functional electrical stimulation (FES)
Description: FES is a technique that electrically stimulates a muscle in a comfortable manner in order to contract the muscle. It uses an electrode placed on the surface of the skin. This study will use BCI, FES, and motor learning interventions to address upper extremity motor deficits following stroke.
Study NCT00746525 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motor learning
Description: Motor learning is an exercise that uses movements needed for everyday tasks such as picking up a glass or opening a book. This study will use BCI, FES, and motor learning interventions to address upper extremity motor deficits following stroke.
Study NCT00746525 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Brain computer interface (BCI) training
Description: BCI training uses signals produced by the brain to help individuals with stroke move their weak arm. This study will use BCI, FES and motor learning interventions to address upper extremity motor deficits following stroke.
Study NCT00444925 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fesoterodine fumarate
Description: 4 mg once daily (OD) for 1 week followed by a forced dose-escalation to 8 mg once daily (OD) for 11 weeks
Study NCT00444925 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: once daily (OD)for 12 weeks
Study NCT00993070 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capsaicin
Description: 0.025% topical capsaicin applied 4 times per day for 8 weeks
Study NCT00993070 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: vehicle gel, applied 4 times per day for 8 weeks
Study NCT01032837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oseltamivir
Description: Oseltamivir capsules for participants ≥ 13 years.
Study NCT01032837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oseltamivir
Description: Pediatric suspension for participants aged ≤ 12 years.
Study NCT01800279 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Deontology Therapy
Description: For the realization of the splint, the following protocol will be developed at the Faculty of Dentistry of Granada (Spain):~* Impression of the maxilla with chromatic alginate Phase plus (Zhermack ©, Rovigo, Italy).~* Emptying working models in plaster-stone type IV Elite Rock (Zhermack ©, Rovigo, Italy).~* Deprogramming occlusal splints were made of polyester plates with terephthalic acid of 3 mm thick Clear 120 model (Dentaflux ©, Ripoll, Madrid). We used a molding machine of thermoplastic vacuum plate The Machine Dentaflux ©, Ripoll, Madrid.
Study NCT02854553 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transversus abdominis plane block
Description: ultra sound guides Transversus abdominis plane block
Study NCT01032837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching placebo provided as capsules and as a suspension.
Study NCT02746796 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ONO-4538
Study NCT02746796 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Study NCT02746796 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Oxaliplatin
Study NCT02746796 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tegafur- Gimeracil-Oteracil potassium
Study NCT02746796 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Tegafur- Gimeracil-Oteracil potassium
Study NCT02746796 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Study NCT02746796 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Capecitabine
Study NCT02746796 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT02271568 — intervention group
Intervention type: PROCEDURE
Intervention: Bariatric surgery
Description: Laparoscopic or Robot R-Y gastric bypass